Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
UK medical equipment manufacturer with clinically proven blood circulation stimulation device seeking investors for expansion to the United States
| Project region | Britain |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | Raise £ 30-35 million Total valuation £ 114 million |
|---|---|
| Project description |
The company has developed patented neuromuscular electrical stimulation technology and a product that has been clinically proven to increase blood circulation. The product is the size of a watch and is worn behind the knee. It will send a small electric pulse to gently stimulate the common peroneal nerve behind the knee, and then activate the calf and foot muscle pump of the calf to return the blood to the heart. The technique has been developed for the treatment of deep venous thrombosis, advanced wound care, preoperative and postoperative edema reduction, incontinence and athlete rehabilitation. In each clinical field, it improves the prognosis of patients and saves sanitation system resources. The company is raising £ 30-35 million to continue clinical development, product development and marketing in the United States, valued at £ 114 million. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us